Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
23000
More than stores (number of affiliated clinics, dispensing pharmacies and drugstores)Wording
Conditional
How definitive the wording is.Announced details
SOKUYAKU (ソクヤク), an online medical consultation, medication guidance and prescription drug delivery serviceSOKUYAKU Online Medical Consultation
Applicable field (uses covered by this announcement)
In-person medication counseling at pharmacies after online medical consultations, dispensing and medication counseling, and community healthcare
Launch date1 June 2026 (already implemented; release date)
What the company reported numerically
Usage history
More than 23,000 affiliated locations in total, including clinics, dispensing pharmacies and drugstores
Offering price
No registration fee or annual fee; the SOKUYAKU Premium plan costs ¥550 per month, including tax.
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | SOKUYAKU (ソクヤク), an online medical consultation, medication guidance and prescription drug delivery service, SOKUYAKU Online Medical Consultation |
| Offering price | No registration fee or annual fee; the SOKUYAKU Premium plan costs ¥550 per month, including tax. |
| Launch date | 1 June 2026 (already implemented; release date) |
| Applicable area | In-person medication counseling at pharmacies after online medical consultations, dispensing and medication counseling, and community healthcare |
| Usage history | More than 23,000 affiliated locations in total, including clinics, dispensing pharmacies and drugstores |
Items this document does not state (13)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Based on the dispensing fee revision effective 1 June 2026, to ease the concentration of prescription processing, expand patient options and support pharmacy operations.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.